Healthcare provider profile · identity verified

Melissa Sue Auer

Internal Medicine · BETHLEHEM, PA · NPI 1992063556

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	694	206
Levothyroxine Sodium	Levothyroxine Sodium	511	131
Lisinopril	Lisinopril	483	136
Amlodipine Besylate	Amlodipine Besylate	476	131
Simvastatin	Simvastatin	326	85
Losartan Potassium	Losartan Potassium	240	70
Omeprazole	Omeprazole	238	67
Rosuvastatin Calcium	Rosuvastatin Calcium	226	61
Pantoprazole Sodium	Pantoprazole Sodium	200	58
Metformin Hcl	Metformin Hcl	194	58
Metoprolol Succinate	Metoprolol Succinate	187	54
Hydrochlorothiazide	Hydrochlorothiazide	177	51
Trazodone Hcl	Trazodone Hcl	173	52
Gabapentin	Gabapentin	164	57
Duloxetine Hcl	Duloxetine Hcl	143	36
Sertraline Hcl	Sertraline Hcl	142	46
Metformin Hcl Er	Metformin Hcl	140	40
Furosemide	Furosemide	131	25
Metoprolol Tartrate	Metoprolol Tartrate	127	30
Escitalopram Oxalate	Escitalopram Oxalate	124	32
Famotidine	Famotidine	116	44
Eliquis	Apixaban	105	21
Pravastatin Sodium	Pravastatin Sodium	86	22
Atenolol	Atenolol	84	23
Glimepiride	Glimepiride	82	22
Albuterol Sulfate Hfa	Albuterol Sulfate	78	33
Fluoxetine Hcl	Fluoxetine Hcl	76	23
Synthroid	Levothyroxine Sodium	76	20
Fluticasone Propionate	Fluticasone Propionate	75	32
Alprazolam	Alprazolam	70	28
Ozempic	Semaglutide	68	16
Montelukast Sodium	Montelukast Sodium	60	14
Valsartan	Valsartan	56	12
Zolpidem Tartrate	Zolpidem Tartrate	56	14
Carvedilol	Carvedilol	55	19
Tramadol Hcl	Tramadol Hcl	55	12
Citalopram Hbr	Citalopram Hydrobromide	53	16
Jardiance	Empagliflozin	50	16
Clopidogrel	Clopidogrel Bisulfate	49	15
Mirtazapine	Mirtazapine	39	14
Potassium Chloride	Potassium Chloride	39	15
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	38	suppressed
Lorazepam	Lorazepam	38	suppressed
Ezetimibe	Ezetimibe	33	suppressed
Warfarin Sodium	Warfarin Sodium	32	suppressed
Bupropion Xl	Bupropion Hcl	31	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Spironolactone	Spironolactone	30	suppressed
Clonidine Hcl	Clonidine Hcl	29	suppressed
Meloxicam	Meloxicam	28	11
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Buspirone Hcl	Buspirone Hcl	27	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	27	suppressed
Alendronate Sodium	Alendronate Sodium	26	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	13
Topiramate	Topiramate	24	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Ipratropium Bromide	Ipratropium Bromide	22	suppressed
Klor-Con M20	Potassium Chloride	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Hydrocortisone	Hydrocortisone	20	12
Meclizine Hcl	Meclizine Hcl	20	12
Allopurinol	Allopurinol	19	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Lovastatin	Lovastatin	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Tradjenta	Linagliptin	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Diazepam	Diazepam	16	suppressed
Clonazepam	Clonazepam	15	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Desloratadine	Desloratadine	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	11
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Glipizide	Glipizide	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Norethindrone Acetate	Norethindrone Acetate	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Naproxen	Naproxen	11	suppressed
Prednisone	Prednisone	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error